PsiThera
PrivateLast Round
Series A
Dec 10, 2025
Total Funding Raised
$95M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PsiThera is a biotechnology company that develops oral small-molecule medicines for immunology and inflammatory diseases using its proprietary QUAISAR computational intelligence platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PsiThera Comparables
Compare PsiThera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fathom Therapeutics | 89% | |
| Forward Therapeutics | 88% | |
| Genesis Molecular AI | 84% | |
PsiThera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 10, 2025 | ||||
| Series A | Dec 10, 2025 |
PsiThera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lightstone Ventures | Series A |
| Eurofarma Ventures | Series A |
| Samsara BioCapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Eric Shaff, formerly of Seres Therapeutics, named new CEO.
- Dec 10, 2025
$48M round completed.
PsiThera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PsiThera's valuation, stock price, and market status.